Role of imaging in rare COVID-19 vaccine multiorgan complications

Cau R.;Mantini C.;Monti L.;Mannelli L.;Di Dedda E.;Mahammedi A.;Nicola R.;Roubil J.;Suri J. S.;Cerrone G.;Fanni D.;Faa G.;Carriero A.;Scuteri A.;Francone M.;Saba L.

Last

2022-01-01

---

Abstract

As of September 18th, 2021, global casualties due to COVID-19 infections approach 200 million, several COVID-19 vaccines have been authorized to prevent COVID-19 infection and help mitigate the spread of the virus. Despite the vast majority having safely received vaccination against SARS-COV-2, the rare complications following COVID-19 vaccination have often been life-threatening or fatal. The mechanisms underlying (multi) organ complications are associated with COVID-19, either through direct viral damage or from host immune response (i.e., cytokine storm). The purpose of this manuscript is to review the role of imaging in identifying and elucidating multiorgan complications following SARS-COV-2 vaccination—making clear that, in any case, they represent a minute fraction of those in the general population who have been vaccinated. The authors are both staunch supporters of COVID-19 vaccination and vaccinated themselves as well.